Given that the metabolite SA is structurally similar to α-KG, an important regulator of the PHD2/HIF-1α axis, we assumed that accumulated SA may be responsible for activating the HIF-1α signaling pathway in GSTZ1-deficient hepatoma cells. Here, EGLN1 is linked to hepatocellular carcinoma.